Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 9/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21626324 | 1.00 | NAAA (0.33) | NAAA | |
| SCHEMBL9658995 | 0.78 | — | — | |
| SCHEMBL3346143 | 0.78 | — | — | |
| SCHEMBL9811273 | 0.77 | NAAA (0.40) | NAAA | |
| SCHEMBL9811251 | 0.77 | CCR2 (0.37) | NAAA | |
| SCHEMBL9811270 | 0.77 | NAAA (0.40) | NAAA | |
| SCHEMBL9811245 | 0.77 | CCR2 (0.37) | NAAA | |
| SCHEMBL9811278 | 0.77 | NAAA (0.40) | NAAA | |
| SCHEMBL9811313 | 0.73 | GAA (0.57) | NAAA | |
| SCHEMBL9811323 | 0.73 | GAA (0.57) | NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746111-B2 | Siderophore conjugated pyrazolidinones, and analogues thereof | YALE UNIVERSITY (US) | 2023-09-05 | — | — | US | disclosed |
| WO-2020018929-A1 | SIDEROPHORE CONJUGATED PYRAZOLIDINONES, AND ANALOGUES THEREOF | YALE UNIVERSITY (US) | 2020-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746111-B2 | Siderophore conjugated pyrazolidinones, and analogues thereof | SLC40A1, HAMP, SLC39A11 | NAAA 2492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.